PriceTargets.com logo

Heska - HSKA Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $123.00
  • Forecasted Upside: 42.54%
  • Number of Analysts: 4
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$86.29 As of 02/6/2023 01:00 AM ET
▼ -2.19 (-2.48%)

This chart shows the closing price for HSKA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Heska Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HSKA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HSKA

Analyst Price Target is $123.00
▲ +42.54% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Heska in the last 3 months. The average price target is $123.00, with a high forecast of $165.00 and a low forecast of $58.00. The average price target represents a 42.54% upside from the last price of $86.29.

This chart shows the closing price for HSKA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 polled investment analysts is to buy stock in Heska. This rating has held steady since November 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/15/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/13/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
2/11/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
5/12/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
8/10/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
11/8/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
1/7/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
2/6/2023

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/6/2023Morgan StanleyDowngradeEqual Weight ➝ Underweight$58.00Low
11/14/2022Piper SandlerLower TargetOverweight$170.00 ➝ $165.00Low
11/9/2022Morgan StanleyLower TargetEqual Weight$149.00 ➝ $135.00Low
11/9/2022Alliance Global PartnersLower TargetBuy$155.00 ➝ $119.00Low
10/17/2022JPMorgan Chase & Co.Lower TargetOverweight$175.00 ➝ $150.00Low
8/22/2022Piper SandlerBoost Target$170.00Low
8/16/2022Piper SandlerBoost TargetOverweight$165.00 ➝ $170.00Low
5/19/2022Alliance Global PartnersBoost Target$150.00 ➝ $155.00Low
5/15/2022Piper SandlerLower TargetNA$190.00 ➝ $180.00High
5/10/2022Alliance Global PartnersLower Target$240.00 ➝ $150.00High
3/17/2022Piper SandlerLower TargetOverweight$210.00 ➝ $190.00High
3/2/2022Alliance Global PartnersLower Target$310.00 ➝ $240.00Low
3/1/2022Morgan StanleyLower TargetEqual Weight$190.00 ➝ $161.00Low
2/23/2022JPMorgan Chase & Co.Lower TargetOverweight$300.00 ➝ $250.00High
11/18/2021Morgan StanleyInitiated CoverageEqual Weight$190.00Medium
8/4/2021Alliance Global PartnersReiterated RatingBuy$240.00 ➝ $310.00Low
8/4/2021Piper SandlerBoost TargetOverweight$240.00 ➝ $305.00Medium
7/12/2021GuggenheimUpgradeNeutral ➝ Buy$280.00High
5/10/2021Piper SandlerBoost TargetOverweight$220.00 ➝ $240.00Medium
5/7/2021Alliance Global PartnersBoost TargetMarket Perform ➝ Buy$230.00 ➝ $240.00Medium
2/25/2021Raymond JamesBoost TargetOutperform$145.00 ➝ $225.00High
2/24/2021Alliance Global PartnersReiterated RatingBuy$167.50 ➝ $230.00High
2/23/2021Piper SandlerBoost TargetOverweight$157.00 ➝ $220.00High
1/29/2021JPMorgan Chase & Co.Initiated CoverageOverweight$195.00High
11/23/2020Piper SandlerBoost TargetOverweight$150.00 ➝ $157.00Medium
11/19/2020Raymond JamesBoost TargetOutperform$140.00 ➝ $145.00High
11/4/2020Alliance Global PartnersBoost TargetBuy$116.50 ➝ $163.50High
10/21/2020Raymond JamesUpgradeMarket Perform ➝ Outperform$125.00High
8/5/2020Alliance Global PartnersBoost TargetBuy$90.00 ➝ $116.50Medium
8/5/2020Piper SandlerUpgradeNeutral ➝ Overweight$87.00 ➝ $110.00High
5/25/2020Piper SandlerLower Target$107.00 ➝ $87.00Medium
5/8/2020Alliance Global PartnersBoost Target$78.00 ➝ $90.00High
4/3/2020Alliance Global PartnersLower TargetAverage ➝ Buy$137.00 ➝ $78.00Low
3/27/2020SidotiLower TargetNeutral$77.00 ➝ $59.00High
1/22/2020Piper SandlerBoost TargetNeutral$86.00 ➝ $107.00Low
1/15/2020SidotiBoost TargetNeutral$72.00 ➝ $77.00High
11/7/2019Raymond JamesDowngradeOutperform ➝ Market PerformMedium
9/18/2019Piper Jaffray CompaniesInitiated CoverageNeutral$68.00Low
5/23/2019GuggenheimInitiated CoverageNeutral ➝ NeutralHigh
2/27/2019B. RileyLower TargetNeutral ➝ Neutral$93.00 ➝ $87.00High
2/27/2019BenchmarkDowngradeBuy ➝ HoldLow
2/26/2019SidotiDowngradeBuy ➝ NeutralLow
7/19/2018BenchmarkInitiated CoverageBuy$120.00Medium
5/21/2018BenchmarkBoost TargetBuy$120.00 ➝ $143.00Low
5/18/2018B. RileyBoost TargetNeutral$77.00 ➝ $93.00Low
5/7/2018BenchmarkBoost TargetBuy ➝ Buy$90.00 ➝ $100.00Medium
3/1/2018B. RileyLower TargetNeutral ➝ Neutral$93.00 ➝ $77.00High
2/26/2018B. RileySet TargetHold$93.00Medium
(Data available from 2/7/2018 forward)

News Sentiment Rating

1.06 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/11/2022
  • 5 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/10/2022
  • 6 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/9/2022
  • 4 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/9/2022
  • 2 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/8/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
12/8/2022
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/7/2023
  • 7 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/6/2023

Current Sentiment

  • 7 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Heska logo
Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through the North America and International segments. The North America segment includes the United States, Canada, and Mexico. The International segment involves Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.
Read More

Today's Range

Now: $86.29
Low: $85.92
High: $89.70

50 Day Range

MA: $71.80
Low: $60.21
High: $93.15

52 Week Range

Now: $86.29
Low: $57.83
High: $154.85

Volume

134,360 shs

Average Volume

138,198 shs

Market Capitalization

$934.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.54

Frequently Asked Questions

What sell-side analysts currently cover shares of Heska?

The following Wall Street sell-side analysts have issued reports on Heska in the last twelve months: Alliance Global Partners, JPMorgan Chase & Co., Morgan Stanley, Piper Sandler, StockNews.com, and TheStreet.
View the latest analyst ratings for HSKA.

What is the current price target for Heska?

4 Wall Street analysts have set twelve-month price targets for Heska in the last year. Their average twelve-month price target is $123.00, suggesting a possible upside of 42.5%. Piper Sandler has the highest price target set, predicting HSKA will reach $165.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $58.00 for Heska in the next year.
View the latest price targets for HSKA.

What is the current consensus analyst rating for Heska?

Heska currently has 1 sell rating and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HSKA will outperform the market and that investors should add to their positions of Heska.
View the latest ratings for HSKA.

What other companies compete with Heska?

Other companies that are similar to Heska include Meridian Bioscience, Myriad Genetics, Celldex Therapeutics, Intellia Therapeutics and Collegium Pharmaceutical. Learn More about companies similar to Heska.

How do I contact Heska's investor relations team?

Heska's physical mailing address is 3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO, 80538. The medical research company's listed phone number is (970) 493-7272 and its investor relations email address is [email protected] The official website for Heska is www.heska.com. Learn More about contacing Heska investor relations.